Quotes 5-day view Real-time Euronext Paris
01/22/2021
01/25/2021
01/26/2021
01/27/2021
01/28/2021
Date
329.8(c)
335.8(c)
334(c)
342(c)
334.2 Last
59 375
70 506
65 169
125 284
43 637 Volume
+2.30% +1.82% -0.54% +2.40% -2.28% Change
Sales 2020
1 877 M 2 270 M 2 270 M
Net income 2020
342 M 413 M 413 M
Net Debt 2020
261 M 316 M 316 M
P/E ratio 2020
91,9x
Yield 2020
0,27%
Sales 2021
2 283 M 2 760 M 2 760 M
Net income 2021
421 M 509 M 509 M
Net Debt 2021
164 M 199 M 199 M
P/E ratio 2021
74,3x
Yield 2021
0,34%
Capitalization
31 526 M 38 134 M 38 118 M
EV / Sales 2020
16,9x
EV / Sales 2021
13,9x
Nbr of Employees
6 979
Free-Float
25,7%
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and...
Notations Surperformance© of Sartorius Stedim Biotech
Trading Rating : Investor Rating :
All news about SARTORIUS STEDIM BIOTECH
News in other languages on SARTORIUS STEDIM BIOTECH
Analyst Recommendations on SARTORIUS STEDIM BIOTECH
SARTORIUS STEDIM BIOTECH - 2020
The underlying trend is to the upside
BUY
Chart SARTORIUS STEDIM BIOTECH
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends SARTORIUS STEDIM BIOTECH
Short Term Mid-Term Long Term Trends Bullish Neutral Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
HOLD
Number of Analysts
8
Average target price
289,63 €
Last Close Price
342,00 €
Spread / Highest target
13,5%
Spread / Average Target
-15,3%
Spread / Lowest Target
-43,6%
Please enable JavaScript in your browser's settings to use dynamic charts.
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
